%0 Journal Article
%T From Tumor Macroenvironment to Tumor Microenvironment: The Prognostic Role of the Immune System in Oral and Lung Squamous Cell Carcinoma.
%A Battista RA
%A Pini GM
%A Finco A
%A Corso F
%A Galli A
%A Arrigoni G
%A Doglioni C
%A Callea M
%A Paccagnella M
%A Porcu L
%A Filipello F
%A Mazzola M
%A Foggetti G
%A Gregorc V
%A Giordano L
%A Bussi M
%A Mirabile A
%A Veronesi G
%J Cancers (Basel)
%V 16
%N 15
%D 2024 Aug 3
%M 39123486
%F 6.575
%R 10.3390/cancers16152759
%X BACKGROUND: The interplay between cancer cells and the immune system is crucial in cancer progression and treatment. In this regard, the tumor immune microenvironment and macroenvironment, marked by systemic inflammation markers and TILs, could be considered key prognostic factors in tumors, including oral and lung squamous cell carcinoma.
METHODS: We conducted a retrospective clinical study on patients with Oral Squamous Cell Carcinoma (OSCC) and Lung Squamous Cell Carcinoma (LUSCC), examining stages, comorbidities, treatments, and outcomes. We evaluated the prognostic significance of pre-surgical systemic inflammation markers and tumor microenvironment composition.
RESULTS: Associations were found between systemic inflammation markers-NLR, MLR, and PLR-and tumor microenvironment factors, such as TILs and CD8+ cell prevalence-elevated inflammation markers correlated with advanced stages. Specifically, NLR was prognostic in OSCC, whereas PLR was prognostic in LUSCC. Using a cutoff value, we divided our tumor samples into two prognostic groups. Moreover, TILs levels >15% of tumor stroma correlated with prolonged overall survival in both OSCC and LUSCC, while increased CD8+ expression was linked to extended disease-free survival in LUSCC.
CONCLUSIONS: Systemic inflammation markers and TILs can be valuable prognostic factors of survival, highlighting the immune response's role in OSCC and LUSCC. Despite limited clinical integration of the presented cohorts due to a lack of standardization, we concluded that analyzing tumor immune profiles may offer novel prognostic insights.
CONCLUSIONS: Future integration into cancer classification could improve risk stratification and treatment guidance.